rs1998721

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000069.3(CACNA1S):​c.1828-5T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.777 in 1,613,192 control chromosomes in the GnomAD database, including 490,367 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 40485 hom., cov: 33)
Exomes 𝑓: 0.78 ( 449882 hom. )

Consequence

CACNA1S
NM_000069.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00006350
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.512

Publications

20 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • congenital myopathy 18
    Inheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myopathy
    Inheritance: SD, AD, AR Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-201075620-A-G is Benign according to our data. Variant chr1-201075620-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 254804.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.938 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.1828-5T>C
splice_region intron
N/ANP_000060.2Q13698

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.1828-5T>C
splice_region intron
N/AENSP00000355192.3Q13698
CACNA1S
ENST00000367338.7
TSL:5
c.1828-5T>C
splice_region intron
N/AENSP00000356307.3B1ALM3
CACNA1S
ENST00000681874.1
c.1828-5T>C
splice_region intron
N/AENSP00000505162.1A0A7P0T8M7

Frequencies

GnomAD3 genomes
AF:
0.721
AC:
109599
AN:
152054
Hom.:
40463
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.550
Gnomad AMI
AF:
0.863
Gnomad AMR
AF:
0.733
Gnomad ASJ
AF:
0.786
Gnomad EAS
AF:
0.961
Gnomad SAS
AF:
0.898
Gnomad FIN
AF:
0.788
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.776
Gnomad OTH
AF:
0.708
GnomAD2 exomes
AF:
0.782
AC:
196572
AN:
251416
AF XY:
0.792
show subpopulations
Gnomad AFR exome
AF:
0.546
Gnomad AMR exome
AF:
0.720
Gnomad ASJ exome
AF:
0.782
Gnomad EAS exome
AF:
0.960
Gnomad FIN exome
AF:
0.780
Gnomad NFE exome
AF:
0.776
Gnomad OTH exome
AF:
0.782
GnomAD4 exome
AF:
0.782
AC:
1143172
AN:
1461020
Hom.:
449882
Cov.:
45
AF XY:
0.786
AC XY:
571534
AN XY:
726850
show subpopulations
African (AFR)
AF:
0.542
AC:
18141
AN:
33450
American (AMR)
AF:
0.723
AC:
32353
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
20426
AN:
26116
East Asian (EAS)
AF:
0.965
AC:
38285
AN:
39690
South Asian (SAS)
AF:
0.885
AC:
76359
AN:
86250
European-Finnish (FIN)
AF:
0.781
AC:
41731
AN:
53418
Middle Eastern (MID)
AF:
0.760
AC:
4380
AN:
5764
European-Non Finnish (NFE)
AF:
0.778
AC:
864256
AN:
1111238
Other (OTH)
AF:
0.782
AC:
47241
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
11842
23684
35525
47367
59209
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20534
41068
61602
82136
102670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.721
AC:
109666
AN:
152172
Hom.:
40485
Cov.:
33
AF XY:
0.725
AC XY:
53961
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.550
AC:
22809
AN:
41494
American (AMR)
AF:
0.733
AC:
11216
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.786
AC:
2729
AN:
3472
East Asian (EAS)
AF:
0.961
AC:
4974
AN:
5178
South Asian (SAS)
AF:
0.899
AC:
4335
AN:
4824
European-Finnish (FIN)
AF:
0.788
AC:
8342
AN:
10592
Middle Eastern (MID)
AF:
0.704
AC:
207
AN:
294
European-Non Finnish (NFE)
AF:
0.776
AC:
52764
AN:
67996
Other (OTH)
AF:
0.712
AC:
1505
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1520
3040
4559
6079
7599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.756
Hom.:
45807
Bravo
AF:
0.708
Asia WGS
AF:
0.915
AC:
3179
AN:
3478
EpiCase
AF:
0.767
EpiControl
AF:
0.767

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Hypokalemic periodic paralysis, type 1 (2)
-
-
2
not provided (2)
-
-
1
Malignant hyperthermia, susceptibility to, 5 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C2749982:Thyrotoxic periodic paralysis, susceptibility to, 1;C3714580:Hypokalemic periodic paralysis, type 1 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.36
DANN
Benign
0.42
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000063
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1998721; hg19: chr1-201044748; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.